首页|拉贝洛尔联合硫酸镁注射液对妊娠高血压综合征患者的影响

拉贝洛尔联合硫酸镁注射液对妊娠高血压综合征患者的影响

扫码查看
目的 探究拉贝洛尔联合硫酸镁注射液对妊娠高血压综合征(PIH)患者的影响.方法 选择 2021 年 2 月—2023 年 2 月莒县人民医院收治的 70 例PIH患者为研究对象,按照随机数字表法将其分为对照组和观察组,各 35 例.对照组采用硫酸镁治疗,观察组在对照组的基础上联用盐酸拉贝洛尔治疗,两组均持续用药直至患者分娩.对比两组临床疗效、血压控制、生理指标、妊娠结局及不良反应发生情况.结果 治疗后,观察组治疗总有效率为 97.14%,高于对照组的 74.29%,差异有统计学意义(P<0.05).治疗后,观察组舒张压及收缩压分别为(84.32±9.11)mmHg及(132.68±8.16)mmHg,均低于对照组的(90.71±8.03)mmHg和(142.09±9.31)mmHg,组间差异有统计学意义(P<0.05);观察组 24h尿蛋白、白细胞介素-6 及同型半胱氨酸分别为(1.25±0.24)g、(22.17±3.34)pg/mL和(11.15±1.07)μmol/L,均低于对照组的(1.89±0.81)g、(30.15±4.26)pg/mL和(13.44±1.21)umol/L,组间差异有统计学意义(P<0.05).观察组不良妊娠结局发生率较对照组低,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论 拉贝洛尔与硫酸镁注射液联合治疗PIH效果确切,能够有效改善患者的血压水平,调节患者生理指标,减少不良妊娠结局发生风险,具有一定安全性.
Effect of Labetalol Combined with Magnesium Sulfate Injection on Patients with Pregnancy Induced Hypertension
Objective To investigate the effect of labetalol combined with magnesium sulfate injection on patients with pregnancy induced hypertension(PIH).Methods A total of 70 patients with PIH treated in Juxian People's Hospital from February 2021 to February 2023 were selected as the research objects,and were divided into a control group and an observation group according to random number table method,with 35 cases in each group.The control group was treated with magnesium sulfate,and the observation group was treated with hydrochloride labetalol on the basis of the control group,and the two groups were continued to take medication until the patient gave birth.The clinical efficacy,blood pressure control,physiological indexes,pregnancy outcome of adverse reactions were compared between the two groups.Results After treatment,the total effective rate of the observation group was 97.14%,which was higher than 74.29%of the control group,the difference was statistically significant(P<0.05).After treatment,the diastolic blood pressure and systolic blood pressure of the observation group were(84.32±9.11)mmHg and(132.68±8.16)mmHg,respectively,which were lower than(90.71±8.03)mmHg and(142.09±9.31)mmHg of the control group,the differences were statistically significant between the two groups(P<0.05);24 h urinary protein,interleukin-6 and homocysteine in the observation group were(1.25±0.24)g,(22.17±3.34)pg/mL and(11.15±1.07)μmol/L,respectively,which were lower than(1.89±0.81)g,(30.15±4.26)pg/mL and(13.44±1.21)umol/L in the control group,the differences between the two groups were statistically significant(P<0.05).The incidence of adverse pregnancy outcome in the observation group was lower than that in the control group,the difference was statistically significant(P<0.05);there was no significant difference in the incidence adverse reactions between the two groups(P>0.05).Conclusion The labetalol combined with magnesium sulfate injection in treatment of patie nts with PIH is effective,can effectively improve the blood pressure level of patients,adjust the physiological indicators of patients,reduce the risk of adverse pregnancy outcomes,and has a certain safety.

Pregnancy induced hypertensionLabelolMagnesium sulfate injectionBlood pressurePregnancy outcome

杨月竹、纪法荣、吕荣

展开 >

莒县人民医院产科,山东日照 276500

妊娠高血压综合征 拉贝洛尔 硫酸镁注射液 血压 妊娠结局

2024

反射疗法与康复医学

反射疗法与康复医学

ISSN:
年,卷(期):2024.5(17)